Borreliosis diagnostics is often based on the clinical appearance together with anamnesis and the evidence of specific antibodies.
Fundamentally, a positive Borrelia antibody test is separately no indicator for a therapy or reflects the clinical manifestations. In this case, detection of Borrelia-specific effector T-cells can provide further diagnostic assistance.
The AID LymeSpot Kit detects and measures the Interferon-y expression of Borrelia-specific effector T-cells
Interested in learning whether current clinical programs, research developments, or emerging therapeutic approaches may be relevant to your situation?
Educational and research information only. Individual medical decisions should be made in consultation with qualified healthcare professionals.
